Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
RetroVirox
company
About
RetroVirox is a privately-held biotechnology company dedicated to discovering new treatments for patients with infectious diseases
- 1 - 10
Highlights
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $3M
- Industries
- Biotechnology,Health Care,Health Diagnostics,Innovation Management,Life Science
- Founded date
- Jan 1, 2008
- Number Of Employee
- 1 - 10
- Operating Status
- Active
RetroVirox is an innovative, privately-held biotechnology company dedicated to discovering new treatments for patients with infectious disease.RetroVirox offers its expertise in antiviral assays and cell-based screening for antiviral compounds to other biotechnology and pharmaceutical companies.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$3M
RetroVirox has raised a total of
$3M
in funding over 2 rounds. Their latest funding was raised on
Mar 12, 2015 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 12, 2015 | Grant | $3M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
RetroVirox is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
